Hosted on MSN53m
UBS Downgrades Novartis AG - Depositary Receipt () (NVS)Fintel reports that on February 13, 2025, UBS downgraded their outlook for Novartis AG - Depositary Receipt () (NYSE:NVS) ...
Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback